Service 05 / 05
Licensing & Partnerships.
In-licensing, out-licensing and distribution partnerships for real markets.
We in-license products for Europe, out-license our own brands and portfolio assets, and structure distribution partnerships for selected Latin American markets with a clear evaluation and term process. Every arrangement is built on the same quality and regulatory infrastructure that supports Nervinetten®, EMASEX® and Zellaforte®.
Our approach
Structured evaluation, then a clear term process.
We assess fit against category, regulatory route, channel and quality requirements before commercial terms are discussed. That order avoids the common failure mode of agreeing terms for a product that cannot legally be sold as intended.
As both a licensor and a licensee, we understand the asymmetries on each side — and we write agreements that survive an audit as well as a negotiation.
What you get.
Concrete deliverables — not a strategy deck that dies in a drawer.
-
Asset evaluation
Category, regulatory route, competitive position and channel fit assessed before terms.
-
In-licensing
We take on products for Europe or selected Latin American markets under a defined territorial and channel scope.
-
Out-licensing
Our own brands and portfolio assets licensed into markets we do not serve directly.
-
Distribution agreements
Terms, minimums, quality annexes and exit provisions defined in writing.
-
Quality annex
Responsibilities allocated explicitly between the parties, aligned to GMP/GDP scope.
-
Transition management
Handover of documentation, registration and stock without a gap in supply.
Built for.
Three situations where this service pays for itself.
-
Portfolio owners
You hold rights you cannot commercialise locally and want a partner who carries the operating risk.
-
Regional operators
You want documented European or Latin American assets for your market and need a licensor with clear responsibilities.
-
Strategic exits
You are divesting a product line and need an orderly transition rather than a fire sale.
Common questions.
Straight answers — the rest we cover on a call.
What categories do you in-license?
Pharmaceuticals, OTC and consumer health with a clear regulatory route and defensible pharmacy, specialist or partner-channel fit in the agreed market.
Are your own brands available for licensing?
Selected territories and channels, yes. We discuss availability case by case, with the quality documentation available up front.
How do you structure terms?
After the evaluation phase. Territory, channel, minimums, duration and quality responsibilities are fixed in writing before any commercial launch activity.
Have an asset — or want one?
Tell us which side of the table you are on, the product and the target territory.
Services are scoped to the product, territory and responsibilities agreed with AFZ and qualified partners. National authorisations, MAH roles and reimbursement pathways apply only where legally applicable and explicitly mandated.